Rod sensitivity relative to cone sensitivity in retinitis pigmentosa.
R W Massof, D Finkelstein
https://pubmed.ncbi.nlm.nih.gov/422332/Actively Recruiting
Led by National Eye Institute (NEI) · Updated on 2026-08-06
500
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating how rod and cone photoreceptors function in the eyes of healthy people and those with retinal diseases such as Retinal Degeneration, Retinitis Pigmentosa, and Stargardts Disease. The study aims to determine whether a persons ability to see in low light can serve as a test for the severity of retinal disease, helping detect and monitor changes over time. This observational, case-control study involves up to 500 participants aged five and older. Participants with retinal disease and healthy volunteers undergo a variety of vision tests. These include eye exams, imaging with dilated pupils, visual field tests where participants respond to light stimuli, and electroretinograms ERG to measure retinal signals after dark adaptation. The study uses specialized devices to assess dark adaptation speed, retinal sensitivity, and hyperacuity under low light. Some participants complete patient questionnaires on vision under dim conditions, and a subgroup with retinal disease will have additional ERG sessions to compare with historical clinical data. During visits lasting from 3 to 8 hours, participants undergo eye exams, imaging, and tests of their ability to detect colored light in dark conditions over periods ranging from 5 to 45 minutes. Up to 6 follow-up visits occur over 6 to 12 months to monitor changes. Researchers measure outcomes like dark adaptation kinetics, retinal sensitivity, and hyperacuity, correlating these with patient-reported vision difficulties. The study also aims to establish normal ranges for these measures and develop scaling factors for ERG results. Overall participation may last up to 5 years with multiple visits to track vision changes.
CONDITIONS
Rod and Cone Mediated Function in Retinal Disease
D
Daniel W Claus, R.N.
B
Brett G Jeffrey, Ph.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Eye Institute (NEI)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 to 8 hours
Participants undergo detailed eye exams, imaging with dilated pupils, and vision tests including dark adaptation and retinal sensitivity assessments. Electroretinograms are done for those with retinal disease.
1 visit (in-person)
Duration - 6 to 12 months
Participants return for up to 6 additional visits over 6 to 12 months to repeat eye exams, imaging, and vision tests to monitor changes in retinal function.
Up to 6 visits (in-person)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
R W Massof, D Finkelstein
https://pubmed.ncbi.nlm.nih.gov/422332/David G Birch, Yuquan Wen, Kelly Locke...
https://pubmed.ncbi.nlm.nih.gov/21810977/Gregory R Jackson, Cynthia Owsley, Christine A Curcio
https://pubmed.ncbi.nlm.nih.gov/12067593/National Eye Institute (NEI)
Lead Sponsor